Please login to the form below
Page and Page
This page shows the latest Page and Page news and features for those working in and with pharma, biotech and healthcare.
Q&A: Kay Wesley
It’s a knee-jerk reaction but an unhelpful one, and nearly always not true. ... Part human tragedy but also a comedy and a thriller, this amazing page-turner is told through the eyes of Maud, a woman living with dementia.
Latest news
-
Innovation in the time of coronavirus
Rachel Harris and Clare Bates, from the Page &Page team, said: “Speed was of the essence. ... The Page &Page team is producing all the communication and campaigning to build awareness of the Distancer on behalf of 3D LifePrints.
-
Havas Lynx Group and VCCP Health win big at PM Society Awards
Roche won two Golds and two Silvers, while Reckitt Benckiser took home two Golds. ... Clever use of misdirection and humour keep the viewer engaged from the first frame.
-
NHS plans to cut certain routine tests as part of cost-saving efforts
The list includes diagnostic tests and treatments that patients will only be able to access via the NHS in exceptional situations. ... Labour leader Jeremy Corbyn also recently claimed that a leaked version of a 451-page dossier shows that drug
-
BMS trades blows with investor on Celgene deal merits
BMS isn’t standing idle, and published a 46-page presentation detailing the “clear strategic rationale” and “compelling value proposition” for the merger on a new bestofbiopharma.com website, as well ... Wellington said the deal undervalues BMS,
-
EU27 backs Brexit terms – now the hard part starts for May
The UK government is launching a desperate bid to win support for the 585-page withdrawal agreement and 26-page declaration on the future relationship between the UK and EU before ... operation in regulation and scientific research which will maximise
More from news
Approximately 0 fully matching, plus 108 partially matching documents found.
Latest Intelligence
-
The role of women in science and technology
Looking at the challenge from the bottom-up, this makes sense and is much needed. ... Fortunately, both the legislation and technology exist to make both an easy reality.
-
Why pharma should invest in the education of doctors
That trend is reflected in doctors’ desire for educational modules and non-promotional content. ... The majority of doctors want content to be brief, preferably about half a page in length.
-
Great expectations: the urgent need for common purpose in Alzheimer’s disease
Securing coverage was never going to be a problem. We did not know the trial results in advance, but we knew it would be front-page news whatever it said, and ... There is a vital job for communicators to inform audiences and balance expectations.
-
What digital means for agencies, pharma, patients and doctors
Those who view ‘digital’ as a way of communicating and interacting with people. ... Ultimately, a shift in mindset and structure is essential to any digital journey.
-
Digital, Doctor and Patients
It identifies major data points within digital health and the impact of future milestones predicted for 2020. ... It covers the areas of artificial intelligence, cybersecurity, digital therapeutics, big data, remote patient monitoring, telehealth
More from intelligence
Approximately 1 fully matching, plus 41 partially matching documents found.
Latest appointments
-
imc group bolsters HR & talent division
She has extensive experience of aiding the strategic transformation of companies’ people agenda, in line with current and future business goals. ... Previously, she worked at 90TEN and Engine Group, and brings knowledge in talent management, training
-
New faces at Lucid, 90Ten and Page & Page
Clare Bates joins Page and Page. Page and Page has poached Synergy Medical Communications’ Clare Bates, who joins the healthcare communications agency as its new editorial director. ... Bates has 17 years’ experience developing content for
-
Senior hires at Precision Health Media
Fontana's role is a new one. He will be responsible for “expanding Precision Health Media's coverage of health-focused agencies and brands as its PageMatch page-level targeting ad ... He will also be managing markets like the midwest and categories
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Demonstrating the value of HCP self-serve portals
But, without proper context, traditional metrics like page views, sessions and users are often meaningless or provide a false sense of effectiveness. ... watch the video or scroll the page deep enough to consume one key message or two etc.
-
If your clinical trial doesn’t have a website, do you even exist?
Why clinical study websites need to be patient-centric. Now, the easy option would be to shove all the information you have onto a landing page - HCPs and patients can log ... But outsourcing your website to a specialist can relieve you and your team of
-
Can involving patients in design transform the clinical trial experience?
Because if your motives and expectations of the study are different, and you’re just simply not on the same page about the outcomes of the study and what the materials ... Through individual reflection and group discussions, the patients selected the
-
Improving patient concordance – where does industry fit in?
As economies emerge, governments will be looking at ways to cut spending and reduce costs. ... To find out more and to download other guides from the series, visit.
-
The concordance conundrum: the value of improving patient experience
Number 1: Metamorphosis. COVID-19 has and will continue to change us all. ... Clare Bates is Content Director at Page &Page. To sign up to receive the next article in the series, please visit the Page&Page Media Lab.
More from PMHub
Approximately 0 fully matching, plus 104 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Gilead agrees $21bn buyout of Immunomedics
- New medical communications agency BOLDSCIENCE launches
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- BMS eyes approval for second Opdivo combo in kidney cancer
- Moderna inks R&D agreements with Vertex and Chiesi
- FDA hands BMS and bluebird bio a priority review for ide-cel
- Janssen’s EGFR-targeting treatment regimen shows early benefit in lung cancer
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- Could formulary intelligence be your brand differentiator?
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Porterhouse Medical strengthens its senior management team
PMHub
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...
Latest intelligence
- Could formulary intelligence be your brand differentiator?
- Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
- Improve clinical trials through patient journey mapping
- Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
Quick links
Infographics
